LifeVantage Corporation Revenue and Competitors

Location

$7.6M

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • LifeVantage Corporation's estimated annual revenue is currently $857.1M per year.(i)
  • LifeVantage Corporation received $5.0M in venture funding in March 2010.
  • LifeVantage Corporation's estimated revenue per employee is $438,885
  • LifeVantage Corporation's total funding is $7.6M.

Employee Data

  • LifeVantage Corporation has 1953 Employees.(i)
  • LifeVantage Corporation grew their employee count by 3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.7M310%N/AN/A
#2
$8.6M40-2%N/AN/A
#3
$49M165-6%N/AN/A
#4
$12.9M53-2%N/AN/A
#5
$9.9M46N/AN/AN/A
#6
$6.5M303%N/AN/A
#7
$178.5M529-18%N/AN/A
#8
$17M7030%N/AN/A
#9
$134M3972%N/AN/A
#10
$476.1M123310%$580MN/A
Add Company

LifeVantage is at the forefront of Nutrigenomics, a new form of nutritional science that uses nutrients to create improved health and wellness. Aging is inevitable. And were all painfully aware of the toll it takes on our bodies. Nutrigenomics is serious science. And it's graduated from the laboratory to real-life, creating a platform for products that really work really.

keywords:Biotechnology,Fitness and Wellness,Food & Beverages,Healthcare,Pharmaceuticals,Retail,Social Networking

$7.6M

Total Funding

1953

Number of Employees

$857.1M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

LifeVantage Corporation News

2022-04-13 - LifeVantage to Announce Third Quarter Fiscal Year 2022 Results on May 3, 2022 - Benzinga

SALT LAKE CITY, April 19, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation. LFVN+4.03%+ Free Alerts. announced today that it will release...

2022-04-13 - LifeVantage (NASDAQ:LFVN) Research Coverage Started at ...

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$622.7M21189%N/A
#2
$1039M22494%N/A
#3
$300M2303-3%N/A
#4
$300M24399%N/A
#5
$709.6M281611%N/A

LifeVantage Corporation Funding

DateAmountRoundLead InvestorsReference
2007-10-04$1.1MUndisclosedAspenwood CapitalArticle
2009-04-08$3.5MUndisclosedAspenwood CapitalArticle
2010-03-05$5.0MUndisclosedAspenwood CapitalArticle